Dirk Biskup (PhD) co-founded the human diagnostics company CeGaT GmbH with his wife, Saskia Biskup (MD, PhD). CeGaT was among the first companies worldwide to leverage high-throughput sequencing (NGS) to comprehensively identify genetic mutations causative for various diseases, including cancer. For this pioneering work, CeGaT received several awards. Today, CeGaT is fully owned by the founder family and ranks among the largest sequencing and genetic diagnostics labs in Europe.

Dirk also founded Cenata GmbH, a leader in non-invasive prenatal testing in Germany, and CAG GmbH (now Generatio GmbH), one of the country’s largest animal genetic testing laboratories. He currently also serves as managing director of the MVZ Tübingen GmbH, an outpatient clinic specializing in oncology and gastroenterology care. 
Dirk is co-founder and managing director of cecava GmbH, actively driving the company’s strategic development. cecava is dedicated to advancing cancer treatment with personalized and hence more effective immunotherapies. A first phase I clinical trial addressing glioblastoma patients will start in 2026.

Previously, Dirk held senior leadership roles at Bertelsmann AG, serving as Senior Director in the M&A department, where he contributed to numerous company acquisitions. He also served as CFO at Berryville Graphics, Bertelsmann’s largest U.S. printing facility, and as European CFO of AEG Electric Tools, overseeing its European subsidiaries and holding companies as managing director.

He holds a Master’s degree and a PhD in Business Administration from the University of Hamburg and the University of Bielefeld, Germany, respectively.